Folate levels in hepatocellular carcinoma patients with portal vein thrombosis

BMC Gastroenterology

Table 3 Laboratory parameters and classifications of subjects included in the study

	PVT (n = 78)	NPVT (n = 60)	Controls (n = 70)	PVT versus NPVT(p value)	PVT versus Controls (p value)	NPVT versus Controls (p value)
Bilirubin (mg/dl)	2.87 ± 0.6	2.36 ± 1.02	1.24 ± 0.38	< 0.001	< 0.001	< 0.001
Albumin (g/dl)	3.15 ± 0.42	3.44 ± 0.38	3.96 ± 0.55	< 0.001	< 0.001	< 0.001
INR	2.91 ± 0.54	2.00 ± 0.57	1.22 ± 0.36	< 0.001	< 0.001	< 0.001
Tot cholesterol (mmol/l)	5.77 ± 1.08	5.69 ± 1.01	5.50 ± 1.04	0.659	0.124	0.297
HDL (mmol/l)	1.40 ± 0.36	1.41 ± 0.37	1.46 ± 0.40	0.873	0.338	0.463
LDL (mmol/l)	3.44 ± 0.38	3.48 ± 0.39	3.46 ± 0.37	0.545	0.747	0.765
Triglycerides (mmol/l)	1.57 ± 0.70	1.50 ± 0.68	1.48 ± 0.65	0.556	0.421	0.864
ALT (IU/l)	51.20 ± 10.80	48.20 ± 11.90	34.50 ± 10.20	0.124	< 0.001	< 0.001
AST (IU/l)	49.20 ± 10.60	48.70 ± 10.80	33.10 ± 10.80	0.786	< 0.001	< 0.001
γGT (IU/l)	82.80 ± 10.20	74.90 ± 12.10	27.40 ± 10.80	< 0.001	< 0.001	< 0.001
AFP (mg/l)	236.10 ± 15.80	240.20 ± 14.20	3.20 ± 0.60	0.117	< 0.001	< 0.001
Serum folate (nmol/l)	5.24 ± 2.81	6.84 ± 2.71	8.50 ± 3.01	< 0.001	< 0.001	0.001
Red cell folate (nmol/l)	144.20 ± 30.60	177.80 ± 28.20	294.20 ± 27.80	< 0.001	< 0.001	< 0.001
Total homocysteine (μmol/l)	32.80 ± 12.20	28.20 ± 13.10	10.70 ± 6.90	0.035	< 0.001	< 0.001

PVT, portal vein thrombosis; INR, International normalized ratio; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ALT, alanine transferase; AST, aspartate transferase, γGT, gamma-glutamil-tranferase

ISSN: 1471-230X